DCP.JO JNB
Dis-Chem Pharmacies Limited
1W: +2.6%
1M: -0.8%
3M: -16.6%
YTD: -25.4%
1Y: -20.0%
3Y: +14.7%
5Y: -4.8%
R2,723.00 ($1.63)
+15.00 (+0.55%)
Weekly Expected Move ±2.9%
R2564
R2643
R2721
R2799
R2878
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$39.2B
+8.0% ▲
5Y CAGR: +10.3%
Gross Profit
$8.8B
+7.1% ▲
5Y CAGR: +9.6%
Operating Income
$2.1B
+18.3% ▲
5Y CAGR: +11.0%
Net Income
$1.2B
+19.8% ▲
5Y CAGR: +14.5%
EPS (Diluted)
$1.38
+20.0% ▲
5Y CAGR: +14.5%
EBITDA
$3.3B
+13.2% ▲
5Y CAGR: +12.3%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $26.3B | $30.4B | $32.7B | $36.3B | $39.2B |
| YoY Growth | +9.6% | +15.7% | +7.4% | +11.1% | +8.0% |
| Cost of Revenue | $20.4B | $23.6B | $25.1B | $28.1B | $30.4B |
| Gross Profit | $5.8B | $6.8B | $7.6B | $8.2B | $8.8B |
| Gross Margin | 22.2% | 22.5% | 23.2% | 22.6% | 22.5% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $5.0B | $572M | $790M | $954M | $972M |
| Operating Expenses | $4.6B | $5.2B | $5.8B | $6.4B | $6.7B |
| Operating Income | $1.3B | $1.5B | $1.7B | $1.8B | $2.1B |
| Operating Margin | 4.8% | 5.1% | 5.3% | 4.9% | 5.4% |
| Interest Expense | $417M | $418M | $486M | $586M | $646M |
| Income Before Tax | $941M | $1.2B | $1.4B | $1.4B | $1.6B |
| Tax Expense | $253M | $337M | $389M | $364M | $414M |
| Net Income | $669M | $853M | $1.0B | $984M | $1.2B |
| Net Margin | 2.5% | 2.8% | 3.1% | 2.7% | 3.0% |
| EPS (Diluted) | $0.78 | $0.99 | $1.16 | $1.15 | $1.38 |
| EBITDA | $2.0B | $2.4B | $2.7B | $2.9B | $3.3B |
| Shares Outstanding | 860M | 860M | 860M | 858M | 858M |